White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke.
暂无分享,去创建一个
Ken Arai | Walter N Kernan | Paul E Milbury | Jeffrey B Blumberg | Michael K Parides | Svetlana Lorenzano | K. Furie | W. Kernan | K. Arai | E. Lo | J. Blumberg | N. Rost | P. Milbury | S. Feske | M. Parides | Karen L Furie | Natalia S Rost | Eng H Lo | S. Lorenzano | Zachary A Corbin | Sophia N Hartdegen | Steven K Feske | Zachary A. Corbin | Sophia N. Hartdegen
[1] P. Sandercock,et al. Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.
[2] F. Fazekas,et al. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants. , 1996, Stroke.
[3] Shotai Kobayashi,et al. Correlation of NO Metabolites and 8-Iso-Prostaglandin F2a With Periventricular Hyperintensity Severity , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[4] Jeffrey L. Saver,et al. Cerebral White Matter Hyperintensities on MRI: Current Concepts and Therapeutic Implications , 2006, Cerebrovascular Diseases.
[5] G. Rosenberg,et al. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. , 2011, Stroke.
[6] Leukoaraiosis and dementia: To the editor , 1990 .
[7] E. Air,et al. Clinical Prediction of Functional Outcome After Ischemic Stroke: The Surprising Importance of Periventricular White Matter Disease and Race , 2009, Stroke.
[8] F. Howe,et al. Blood–brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[9] J. Morrow. Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[10] Eric E. Smith,et al. White matter hyperintensity volume is increased in small vessel stroke subtypes , 2010, Neurology.
[11] E. Candelario-Jalil,et al. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. , 2009, Current opinion in investigational drugs.
[12] W. Ding,et al. Electron Paramagnetic Resonance-Guided Normobaric Hyperoxia Treatment Protects the Brain by Maintaining Penumbral Oxygenation in a Rat Model of Transient Focal Cerebral Ischemia , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] Eric E. Smith,et al. Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke , 2009, Neurology.
[14] Paul A Armitage,et al. Changes in Background Blood–Brain Barrier Integrity Between Lacunar and Cortical Ischemic Stroke Subtypes , 2008, Stroke.
[15] RyosukeTakahashi,et al. Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter Lesions After Chronic Cerebral Hypoperfusion in Rodents , 2006 .
[16] D. Mezzapesa,et al. Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke , 2007, Neurological Sciences.
[17] Jeffrey F. Thompson,et al. Matrix Metalloproteinases Are Associated With Increased Blood–Brain Barrier Opening in Vascular Cognitive Impairment , 2011, Stroke.
[18] A Gregory Sorensen,et al. Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke , 2008, Stroke.
[19] K. Sung,et al. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion , 2006, Journal of neuroscience research.
[20] H. Shibasaki,et al. Chronic Cerebral Hypoperfusion Induces MMP-2 but Not MMP-9 Expression in the Microglia and Vascular Endothelium of White Matter , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] J. Garcìa,et al. Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.
[22] J. Helenius,et al. Treatment of leukoaraiosis: a futuristic view. , 2007, Current drug targets.